Share
Santoro Headshot 2025

Society Offers Many Ways for Members to Stay Informed and Make Connections

Knowledge is the fuel that powers the world. Access to timely and accurate information allows us to make informed decisions about our patients, our research, our careers, and our relationships with colleagues. I’m grateful the Endocrine Society provides many different communications channels to generate useful and practical knowledge on every aspect of endocrine science and...
Share

Advocacy Update: July 2026

Endocrine Society Fights to Protect Research from Proposed OMB Rule & Calls on Members to Join our Advocacy On May 29, the Office of Management and Budget (OMB) proposed sweeping changes to the rules governing all federal grant funding. If finalized, this rule would fundamentally reshape how biomedical research, including endocrine science, is funded in the...
Share

Pharma Friday – June 26, 2026

An Endocrine News roundup of the week’s pharmaceutical news, breakthroughs, and general information. * Sanofi’s Tzield Approved in the U.S. for Patients with Stage 3 Type 1 Diabetes On June 13, Sanofi announced that the US Food and Drug Administration (FDA) has granted accelerated approval to Tzield (teplizumab-mzwv) to delay the decline in endogenous (own)...
Share

Breezing Into the Windy City for ENDO 2026

New Headshot While all of ENDO 2026 sessions are can’t miss events, certain ones almost always inspire certain passions among the attendees, and those are the debates! Former Endocrine Society president Stephen Hammes, MD, PhD, moderated the Endocrine Debate session “Low Testosterone in Obesity: Should We Treat or Not?” and Kelly Horvath has taken a deep dive...
Share

Looking Back: Unforgettable Moments from ENDOs Past

EN June 2026 Cover Endocrine Society members share highlights and cherished memories from past annual conferences. Since ENDO 2026 in Chicago is fresh in our minds, Endocrine News quizzed Endocrine Society members to see what their favorite memories of past ENDOs have been. From professional connections to new job leads, lifelong friendships, and even some unforgettable meals, ENDO is...
Share

Pharma Friday – ENDO 2026 Edition – June 19, 2026

An Endocrine News roundup of the week’s pharmaceutical news, breakthroughs, and general information. * Crinetics Presents Full Results From Phase 2 Trial of Atumelnant in CAH at ENDO 2026 On June 14, Crinetics Pharmaceuticals, Inc.  presented data from the open-label, Phase 2 congenital adrenal hyperplasia (CAH) adult study of investigational atumelnant, a novel, once-daily oral...